IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 130 filers reported holding IVERIC BIO INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,846,396 | +59.2% | 148,612 | -1.5% | 0.01% | +60.0% |
| Q1 2023 | $3,672,054 | +12.2% | 150,927 | -1.3% | 0.01% | 0.0% |
| Q4 2022 | $3,273,139 | +56.0% | 152,879 | +30.7% | 0.01% | +25.0% |
| Q3 2022 | $2,098,000 | +84.2% | 116,925 | -1.3% | 0.00% | +100.0% |
| Q2 2022 | $1,139,000 | -42.7% | 118,439 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $1,988,000 | -4.2% | 118,118 | -4.9% | 0.00% | +50.0% |
| Q4 2021 | $2,076,000 | +15.7% | 124,158 | +12.3% | 0.00% | 0.0% |
| Q3 2021 | $1,795,000 | +127.5% | 110,554 | -11.5% | 0.00% | +100.0% |
| Q2 2021 | $789,000 | +5.1% | 124,988 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $751,000 | -10.6% | 121,573 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $840,000 | +22.4% | 121,573 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $686,000 | +97.7% | 121,573 | +78.8% | 0.00% | 0.0% |
| Q2 2020 | $347,000 | – | 68,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |
| PRECEPT MANAGEMENT LLC | 130,000 | $5,114,200 | 6.94% |